重庆医学2013，Vol.42Issue(3)：302-303,2.DOI:10.3969/j.issn.1671-8348.2013.03.025
重症监护病房鲍曼不动杆菌感染现状及耐药性分析
Analysis of infection status and drug resistance of Acinetobacter baumannii in ICU
唐晓铃 1杨缙1
作者信息
- 1. 重庆市第三人民医院重症医学科,400014
- 折叠
摘要
Abstract
Objective To investigate the clinical distribution and drug resistance characteristics of Acinetobacter baumannii (ABA) in ICU. Methods Strain during January 2011 to February 2012 specimens from patients cultured 373 plants of ABA. ABA was separated and identified according to "the national clinical laboratory standards"; the bacteria identification and drug sensitivity were tested by using the French bioMerieux VITEK-2 system,Pseudomonas aeruginosa strains of ATCC27853 were as quality control,the result was judged according to the CLSI standard. Results There were 373 strains of ABA,the detection rate was 21. 4%. ABA detection rate in respiratory specimens occupied the first place,up to 89% ;the same specimen detection of ABA infection complicated with other bacteria was 50. 7% , ABA produced very serious resistance to clinical antibiotic, the resistance rates to imipenem and meropenem were 73. 5% and 82. 0% respectively. Conclusion To control ABA resistance growing trend we should analyze the clinical distribution feature and drug resistance in ABA, advocate drug combination and insist on dynamic monitoring drug DDD value.关键词
鲍曼不动杆菌/抗药性,细菌/重症监护病房Key words
Acinetobacter baumannii/drug resistance,bacterial/intensive care unites引用本文复制引用
唐晓铃,杨缙..重症监护病房鲍曼不动杆菌感染现状及耐药性分析[J].重庆医学,2013,42(3):302-303,2.
